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Abstract
Background: Members of the signal transducer and activator of transcription (Stat) family of transcription factors traverse
the nuclear membrane through a specialized structure, called the nuclear pore complex (NPC), which represents a selective
filter for the import of proteins. Karyophilic molecules can bind directly to a subset of proteins of the NPC, collectively called
nucleoporins. Alternatively, the transport is mediated via a carrier molecule belonging to the importin/karyopherin
superfamily, which transmits the import into the nucleus through the NPC.
Methodology/Principal Findings: In this study, we provide evidence for an alternative Stat1 nuclear import mechanism,
which is mediated by the shuttle protein nucleolin. We observed Stat1-nucleolin association, nuclear translocation and
specific binding to the regulatory DNA element GAS. Using expression of nucleolin transgenes, we found that the nuclear
localization signal (NLS) of nucleolin is responsible for Stat1 nuclear translocation. We show that this mechanism is utilized
upon differentiation of myeloid cells and is specific for the differentiation step from monocytes to macrophages.
Conclusions/Significance: Our data add the nucleolin-Stat1 complex as a novel functional partner for the cell differentiation
program, which is uniquely poised to regulate the transcription machinery via Stat1 and nuclear metabolism via nucleolin.
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Introduction
Human blood monocytes are able to differentiate into
morphologically and functionally heterogeneous effector cells,
including macrophages. The precise molecular mechanisms
responsible for differentiation of circulating monocytes into tissue
macrophages are, however, incompletely defined. Recent studies
highlight the role of transcription factors and other nucleo-
cytoplasmic shuttling proteins in these processes, which require
dynamic changes in gene expression [1,2].
Nucleolin is an ubiquitous multifunctional nucleolar shuttle
phosphoprotein in eukaryotic cells. Its tripartite domain structure,
with an acidic histone-like N-terminus, a central domain
containing four RNA binding domains, and an arginine and
glycine rich C-terminus, reflects the diverse roles of nucleolin in
cell growth, proliferation, and cell death (reviewed in [3–5]).
Nucleolin has been implicated in many cellular activities, including
pre-ribosomal RNA transcription and ribosome biogenesis [6],
replication and recombination of DNA, cell cycle progression [7],
viral infection [8,9], and apoptosis [10–13]. One remarkable
characteristic of nucleolin is that it shuttles constantly between the
nucleus and the cytoplasm [14] and additionally serves in some
cell types as a cell surface receptor [12,15–17]. For the
nucleocytoplasmic translocation, nucleolin uses its bipartite
nuclear localisation signal (NLS) located between the N-terminal
and central domains, and thereby acts as a carrier for karyophilic
proteins [18–20]. A growing body of evidence shows interactions
of nucleolin with transcription factors [6,21–23].
Members of the signal transducer and activator of transcription
(Stat) family of transcription factors are activated during the
myeloid differentiation and may play an important role in the
differentiation program, including those of monocyte-to-macro-
phages [24–26,2,27,28–30]. In response to ligand binding of
cytokines and growth factors to cell surface receptors, the
cytoplasmically located Stats become phosphorylated, form
dimers, enter the nucleus, and bind to specific DNA sequences
that often results in an alteration of gene expression profiles [31].
The exact role of Stat proteins in the regulation of proliferation
and terminal cell differentiation of myeloid cells remains to be
elucidated.
To enter the nucleus, the Stats have to traverse the nuclear
membrane through a specialized structure, called the nuclear pore
complex (NPC), which represents a selective filter for the import of
proteins [32]. Karyophilic molecules can bind directly to a subset
of proteins of the NPC, collectively called nucleoporins [33,34].
Alternatively, the transport is mediated via a carrier molecule
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belonging to the importin/karyopherin superfamily, which binds
to the NLS of the macromolecular cargoes, and transmits the
import into the nucleus through the NPC. For Stat proteins both,
the carrier-independent and the carrier-dependent nucleocyto-
plasmic shuttling have been described [35,36].
The aim of the present work was to analyze a possible
involvement of the multifunctional shuttle protein nucleolin in
myeloid differentiation of monocytic cells to macrophages. We
report that during the monocyte-to-macrophage differentiation,
nucleolin associates with the transcription factor Stat1. This
association is specific for cells of monocytic origin and is involved
in the monocyte-to-macrophage differentiation program. Using
expression of nucleolin transgenes, we found that the NLS
sequence of nucleolin is responsible for Stat1 nuclear translocation
and formation of a ternary complex of nucleolin, Stat1 and the
Stat1 target DNA. Our study provides evidence that in addition to
so far known Stat1 nuclear import mechanisms an alternative
pathway exist, which involves nucleolin-mediated Stat1 transport
to the nucleus.
Results
Nucleolin and Stat1 Associate during Monocyte-to-
Macrophage Differentiation
Nucleolin plays an important role in the differentiation program
of hematopoietic cells [37,38]. As a nucleocytoplasmic shuttle
protein, nucleolin binds to transcription factors and modulates
gene expression during differentiation. To identify binding
partners of nucleolin involved in monocytes differentiation, a
nucleolin affinity matrix precipitation assay was performed. For
this purpose, we used the N-terminal domain lacking nucleolin
construct (DN-Ncl) generated from human cDNA clones,
bacterially expressed as a GST fusion protein and bound to
glutathione agarose. Human myeloid leukaemia THP-1 cells were
stimulated up to four days with the phorbol ester PMA to induce
the differentiation process, and whole cell lysates were used for the
pull-down assay. It has been reported previously that Stat proteins
are activated during myeloid differentiation [2]. Therefore, we
addressed first these transcription factors and analyzed eluates of
our pull-down assays using antibodies against Stat proteins. We
found in these experiments that the transcription factor Stat1, but
not other Stats (Stat2, Stat3, Stat4, Stat5), was specifically bound
to the nucleolin-GST matrix (Fig. 1A and data not shown). This
binding was time-dependent peaking at 72 hrs of PMA treatment.
The macrophage differentiation was monitored by the expression
of specific cell surface proteins (Fig. 1B). In the phase contrast
images and after Wrights-Giemsa staining, PMA treated cells
showed the characteristic macrophage morphology, namely, larger
cell size, increased membrane ruffles, and large cytoplasm
pseudopodia of the adherent cells (Fig. 1C).
To provide further evidence for the nucleolin-Stat1 binding,
several approaches were used. Since the C-terminal glycine/
arginine-rich domain of nucleolin (RGG) was reported to serve for
nucleolin interactions [3], the corresponding nucleolin constructs
(C(Ncl) and DN(Ncl)) were generated, as well as a full-length Stat1
(Fig. 2A). Pull-down assays using both DN(Ncl)-GST and C(Ncl)-
GST, as well as Stat1-GST, confirmed nucleolin- Stat1 binding in
THP-1 cells stimulated for differentiation. These results suggest
that the RGG region of nucleolin is involved in this interaction.
The Stat1-nucleolin binding was additionally found in cells of the
human U937 promyelocytic cell line and in the M1 mouse
myeloid leukemia cells stimulated for differentiation (Fig. 2B). To
assess whether nucleolin and Stat1 might associate in living cells,
co- immunoprecipitation experiments using anti-nucleolin and
Figure 1. Stat1 and nucleolin bind in THP-1 cells in a time-
dependent manner. (A) Nucleolin-GST fusion proteins were bound to
glutathione agarose and used as affinity matrix in a pull-down assay
with whole cell extracts from non-stimulated or PMA (2 nM) stimulated
THP-1 cells. Eluates were analyzed by Western blotting; GST glutathione
agarose was used as control. (B) THP-1 cells treated as described above
were analyzed by FACS analysis. Cell surface expressions of CD11b and
CD36 were used to monitor the process of the monocyte-macrophage
differentiation. (C) Phase contrast picture and Wright-Giemsa staining of
non-stimulated and PMA stimulated THP-1 cells.
doi:10.1371/journal.pone.0008302.g001
Stat1-Nucleolin Complex
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anti-Stat1 antibodies were performed. Indeed, both proteins were
co-immunoprecipitated. Remarkably, nucleolin-Stat1 association
was only observed in cells stimulated for differentiation, but not in
the unstimulated cells (Fig. 2C). As a third approach investigating
Stat1-nucleolin interference, we performed cross-linking studies
(Fig. 2D). Cytosolic proteins of PMA stimulated THP-1 cells were
subjected to cross-linking using chemical cross-linker BS3, followed
by immunoprecipitation with anti-nucleolin (left panel) or anti-
Stat1 antibodies (right panel). An additional high molecular mass
band over 250 kDa was revealed in both experimental settings.
From the molecular mass value, we assume that the complex
contains a Stat1 dimer and nucleolin. These findings implicate a
direct interaction between Stat1 and nucleolin.
Since usage of cell lines and cell stimulation with PMA reflects a
model system, we were interested whether association of nucleolin
with Stat1 might have a physiological relevance. For this purpose,
a full-length human macrophage colony stimulating factor
receptor (M-CSFR), which is a physiological receptor to mediate
monocyte differentiation, was expressed in THP-1 cells by means
of a lentiviral gene transfer. The expressed M-CSFR was
functionally competent and revealed an autophosphorylation in
response to stimulation with its natural ligand, CSF-1 (Fig. 3A).
Pull-down assay demonstrated binding of nucleolin and Stat1 in
M-CSFR expressing THP-1 cells stimulated with CSF-1 (Fig. 3B).
The same results were obtained in highly purified human
peripheral blood derived monocytes (Fig. 3C), but not in cells of
non-monocytic origin like primary vascular smooth muscle cells,
endothelial cells or cells of the fibrosarcoma HT1080 cell line (data
not shown). The increased association of Stat1 with nucleolin upon
cell stimulation was not related to changes in their expression. As
shown in control experiments, neither Stat1 nor nucleolin protein
expression was affected upon the differentiation process (Fig. 3C).
Together, these data indicate that Stat1-nucleolin association is
a physiological phenomenon specific for cells of monocytic origin.
Nucleolin-Stat1complex Translocates into the Nucleus
and Binds to the Stat1 Specific DNA Sequence GAS
Nucleolin can shuttle between the nucleus and the cytoplasm
[14]. Activated Stat proteins form dimers, enter the nucleus, and
bind to specific DNA sequences to affect gene transcription [31].
To investigate the cellular localization of nucleolin and Stat1
during the differentiation process, immunocytochemical studies
were performed. Human primary monocytes were stimulated with
CSF-1 for indicated time points to induce monocyte-to-macro-
phage differentiation. The staining patterns in the confocal images
demonstrated that though Stat1 was mainly expressed in the
cytoplasm and nucleolin in the nucleus, both proteins revealed co-
localization in the perinuclear space followed by their nuclear
translocation. The maximal colocalization of nucleolin and Stat1,
as well as individual colocalization of both proteins with nuclear
marker was observed after 72 hours CSF-1 treatment. At this time
point, most of the cells showed the characteristic macrophage
Figure 2. Stat1-nucleolin complex is specifically formed in cells of monocytic origin. (A) Schematic presentation of nucleolin and Stat1
constructs generated from human cDNA clones to express GST fusion proteins. (B) Different cell lines of monocytic origin cultured for 72 hrs without
or with indicated stimuli were analyzed in pull-down assay using nucleolin- or Stat1-GST fusion proteins bound to glutathione agarose. Respective
anti-Stat1 or anti-Ncl antibody was used for Western blotting of eluates. (C) Co-immunoprecipitation studies with whole-cell extracts from non-
stimulated or PMA stimulated THP-1 cells. Anti-nucleolin or anti-Stat1 antibody coupled to protein A/G-agarose was used as affinity matrix. Eluted
proteins were analyzed by Western blotting with corresponding antibodies to detect Stat1 or nucleolin. (D) Proteins were released by hypotonic
shock of non-stimulated or PMA stimulated THP-1 cells. S100 fractions were subjected to chemical cross-linking using BS3, followed by
immunoprecipitation and Western blotting.
doi:10.1371/journal.pone.0008302.g002
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morphology (Fig. 4A, lower panel). Cell differentiation was
additionally controlled by the expression of the cell surface
macrophage-mannose receptor (CD206) by FACS analysis
(Fig. 4B). The observed nucleolin-Stat1 colocalization was
transient and decreased with longer stimulation.
We next asked whether or not the nucleolin-Stat1 complex
binds to the Stat1 specific DNA sequences after translocation into
the nucleus. In our EMSA, 32P-labeled GAS oligonucleotide was
used as a probe to analyze nuclear extracts from THP-1 cells
activated with PMA for up to 72 hours. Cells stimulated with
interferon-gamma (IFNc), which is one of the most effective Stat1-
activating cytokines, were used as a positive control. The results of
these experiments are presented in Fig. 5. Cell stimulation with
PMA led to the induction of one specific DNA-binding protein
complex migrating in gel more slowly than complex formed in
response to IFNc. The kinetics of the DNA binding activity
correlated with those for the Stat1-nucleolin nuclear translocation
(Fig. 4A). No binding to the GAS was detected in the presence of
excess of unlabeled GAS, whereas an unrelated oligonucleotide
did not affect the DNA-protein binding. To examine the presence
of Stat1 and/or nucleolin in the observed complex, a supershift
assay was performed. The corresponding band was inhibited by
both anti-Stat1 and anti-nucleolin antibody.
These data implicate a role of the nucleolin-Stat1 complex for
the regulated gene expression upon the monocyte differentiation
program.
Nucleolin Serves as a Carrier for the Nuclear
Translocation of Stat1
Molecular mechanisms of Stat1 nuclear translocation have been
intensively studied [39] However, an involvement of nucleolin in
this process has not been reported yet. Therefore, we next
examined whether the observed association of nucleolin and Stat1
is necessary for the transport of this transcription factor into the
nucleus. We specifically inhibited nucleolin expression in THP-1
cells by RNA silencing using a lentiviral RNA interference vector
constructed for this purpose. Up to 70% of infection rate was
achieved by this way (Fig. 6), whereas conventional transfection
reagents showed only low efficiency in cells of monocytic origin
[40].
To elucidate whether nucleolin is required for the nuclear
transport of Stat1, we performed cell fractionation and examined
nuclear extracts isolated from Nclsi-THP-1 cells, non-treated or
treated with PMA for 72 hrs. Specific markers were used to
control the purity of obtained fractions (Fig. 7A). Stat1 enrichment
in nuclear fractions was strongly impaired in PMA stimulated
Nclsi-THP-1 cells, but not in control infected cells. Interestingly,
we found no impact of nucleolin on the Stat1 nuclear transport in
response to IFNc. Thus, although IFNc elicited Stat1 enrichment
in nuclear fractions, there was no difference between the IFNc
stimulated Nclsi-THP-1 cells and control infected cells. In
addition, longer stimulation with IFNc did not show any influence
of nucleolin on the Stat1 nuclear distribution (data not shown).
These data favor a specificity of the nucleolin- dependent Stat1
nuclear translocation for the monocyte-to-macrophage differenti-
ation, which is independent of IFNc.
To verify these findings further, we used Nclsi-THP-1 cells
under the same experimental design for confocal microscopy
studies (Fig. 7B). The staining patterns for Stat1 were consistent
with the results of immunoblotting of the nuclear extracts (Fig. 7A).
Thus, Stat1 nuclear translocation in response to PMA was blocked
in nucleolin down-regulated cells, whereas in control-infected cells
Stat1 was effectively distributed to the nucleus of differentiating
cells (Fig. 7B, upper panels). Independently of the virus construct
and stimulation time used, IFNc stimulated THP-1 cells showed a
clear translocation of Stat1 into to nucleus (Fig. 7B, lower panels,
shown for 2 hrs IFNc stimulation).
Together, these findings demonstrate the requirement of
nucleolin for the nuclear transport of the transcription factor
Stat1 upon the monocyte differentiation process.
Figure 3. Formation of the Stat1-nucleolin complex in human monocytes is mediated by the M-CSFR. (A) Lysates of non-, control- or M-
CSFR- infected THP-1 cells were immunoblotted with anti-M-CSFR antibody (upper left panel). Autophosphorylation of M-CSFR in M-CSFR-expressing
THP-1 cells after stimulation with CSF-1 was detected by phospho-specific anti-M-CSFR IgG (upper right panel). (B) M-CSFR- expressing THP-1 cells
were stimulated with CSF-1 and taken for pull-down experiments. (C) Human peripheral blood-derived monocytes (Mo) were stimulated with CSF-1
and used for pull-down assay as indicated in above. Crude cell lysates were included to demonstrate equal protein expression of Stat1 and Ncl after
CSF-1 stimulation.
doi:10.1371/journal.pone.0008302.g003
Stat1-Nucleolin Complex
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Figure 4. Stat1 and nucleolin are translocated into the nucleus. (A) Primary blood-derived human monocytes were fixed, permeabilized, and
stained using polyclonal anti-nucleolin antibody, monoclonal anti-Stat1 antibody, and the corresponding Alexa coupled secondary antibodies;
simultaneous DNA labelling with DRAQ5 was performed to visualize the nuclear compartment. The merged confocal images of monocytes
stimulated with CSF-1 for indicated time points are shown. The lower panel shows phase contrast pictures. The images were acquired with a
resolution of 1024x1024 pixels with a MRC1024 confocal microscope (BioRad, Hercules, CA) attached to a Nikon Diaphot. All images were taken with
oil-immersed x63 objective, and were recorded for triple staining sequentially with detection wavelengths range for Alexa488, Alexa568 and DRAQ5
(Exlmax 646 nm). Pictures were merged using the Lasersharp software (BioRad). (B) The monocyte-to-macrophage differentiation was monitored by
FACS analysis. Cell surface expression of the macrophage-mannose recepor (CD206) in CSF-1 stimulated (dark grey curve) and non-stimulated
monocytes (open line) are shown. The broken line represents the FITC-isotype control.
doi:10.1371/journal.pone.0008302.g004
Stat1-Nucleolin Complex
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The Stat1-Nucleolin Interference Is Specific for the
Monocyte-to-Macrophage Differentiation Step and
Regulates the Expression of the Macrophage Scavenger
Receptor CD36
Nucleolin is highly expressed in cells of the hematopoietic
system and its important role for basic biological functions in
hematopoietic stem/progenitor cells has been recently demon-
strated [38]. To determine whether nucleolin-mediated Stat1
nuclear translocation is induced in a stage specific manner during
myeolopoiesis, we performed experiments using primary human
bone marrow-derived CD34-positive cells. Cells were stimulated
with CSF-1 to induce differentiation to the monocyte/macrophage
specific unilineage [41]. Differentiation was monitored by
expression of specific markers in FACS analysis. Though both,
nucleolin and Stat1 were constantly expressed over the whole
process of CD34+ cells differentiation, we observed nucleolin-Stat1
binding and nuclear translocation only at the stage of monocyte-
to-macrophage differentiation; nucleolin silencing impaired Stat1
nuclear accumulation (Fig. 8A). To further investigate the stage-
dependent specificity of this effect, we triggered PLB-985 cells to
differentiate to neutrophils and analyzed the nucleolin-Stat1
binding in pull-down assays. A high level of Stat1 expression
was detected in these cells, however, no binding of Stat1 with
nucleolin was observed (Fig. 8B).
To investigate functional consequences of this association for
the monocyte-to-macrophage differentiation process, we analyzed
the expression of genuine macrophage specific markers after
nucleolin silencing. As shown in Fig. 8C, in THP-1 cells, the
expression of CD11b and CD36 was significantly decreased by
about 50% in Nclsi- compared with control cells. The revealed
dependency of the scavenger receptor CD36 on nucleolin is of
special interest, because it has been reported recently, that CD36
serves as a specific Stat1 target gene regulating CD36-directed
foam cell formation in macrophages [42].
Collectively, these data indicate that nucleolin-Stat1 interaction is
specific to the monocyte-to-macrophage step and that intact nucleolin
is required to promote the monocytic scavenger receptor CD36.
Stat1 Nuclear Import Requires the Nuclear Localization
Signal of Nucleolin
Nucleolin shuttles between the cytoplasm and the nucleus, and
its NPC-related carrier function for karyophilic proteins depends
Figure 5. PMA induces binding of a Stat1-nucleolin complex to the GAS element. THP-1 cells were treated with IFNc for 2 h or with PMA
for 24, 48 or 72 h. Whole cell extracts were prepared and used for EMSA. Subunit composition of DNA binding complexes were analyzed by antibody
competition with antibodies directed against Stat1 and nucleolin, as indicated. Complex specificity was verified with oligonucleotide competition,
using 5-fold excess of GAS or H2K, respectively. White arrow indicates Stat1 homodimers; black arrow indicates a Stat1-nucleolin complex.
doi:10.1371/journal.pone.0008302.g005
Figure 6. Nucleolin gene silencing in THP-1 cells. (A) For each experiment, the nucleolin downregulation in the THP-1 by lentiviral gene
silencing was checked on protein level 3 and 6 days post infection by Western blotting of whole cell extracts with monoclonal anti-nucleolin antibody
(upper panel; lower panel demonstrates equal protein loading) or by FACS analysis of fixed and permeabilzed cells (B) or on mRNA level by
quantitative RT-PCR analysis (C).
doi:10.1371/journal.pone.0008302.g006
Stat1-Nucleolin Complex
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on the intact NLS [18–20]. Our next question was to investigate a
role of the nucleolin NLS for the nucleolin-transmitted Stat1
nuclear transport in hematopoietic cells. We used lentiviral gene
transfer to overexpress in a dominant-negative fashion a NLS
deletion mutant form of nucleolin (Fig. 9A). The subcellular
localization of Stat1 was monitored by confocal microscopy; cell
nuclei were defined using specific nuclear markers. As shown in
Fig. 9B, non-differentiating cells showed bright cytoplasmic
staining for Stat1, in contrast to differentiating cells infected with
control virus or expressing full-length nucleolin. In these cells,
Stat1 accumulated in the nucleus. Stat1 remained almost
exclusively cytoplasmic only in the NLS-mutant expressing cells
stimulated for differentiation. Just a faint nuclear Stat1 staining
was occasionally visible, that reflected most likely a low level of
non-competed, wild type nucleolin transmitted transport. These
data indicate a requirement of the NLS sequence for the nucleolin-
directed Stat1 nuclear transport in hematopoietic cells.
Discussion
In this study, we identified a novel molecular mechanism for
Stat1 nuclear transport. This finding represents an alternative
pathway to the already reported Stat1 nuclear translocation
mechanisms, which is mediated by the shuttle protein nucleolin.
The NLS sequence of nucleolin is necessary for the correct
import into the nuclear compartment. The important result of
our experiments is that this mechanism is induced in a stage-
specific manner along the monocyte/macrophage pathway.
Nucleolin deficiency is associated with impaired expression of
monocyte differentiation markers, one of which, the scavenger
receptor CD36, is a Stat1 target gene and plays an important
role in pathophysiological events related to lipid uptake and
inflammation.
Many different mechanisms orchestrate the myeloid develop-
mental program, including cooperative gene regulation, protein-
protein interactions, and induction of cell cycle arrest. We
addressed a role of nucleolin in cell differentiation and identified
the transcription factor Stat1 as a novel and specific binding
partner of nucleolin in hematopoietic cells. Increasing evidence
point to multiple functions of Stat1 in myeloid cells mediating
inflammatory, proapoptotic and antiproliferative events [2,43,44].
These studies suggest that Stat1 may be an early transcription
factor activated during the monocyte maturation process upon
migration into extravascular tissues. They further indicate that
Stat1 does not trigger per se the differentiation process but rather is
a part of a developmental program leading to the regulation the
transcription of genes specific of mature macrophages. Our
findings are along these lines of evidence. We observed the
formation of the Stat1-nucleolin complex and its nuclear
translocation in the later phase of the monocyte-to-macrophage
differentiation. Our results support the studies of others reporting
Stat1 constitutive activation at day five of monocyte cultivation
[2], as well as changes in activation and DNA binding capacity of
LIL-Stat during monocyte maturation [45]. These data suggest
that the effects of Stats are tightly controlled according to the
status of cell differentiation. The underlying molecular events are,
however, sparsely explored.
Specificity of Stat-mediated cellular reactions is a complex
multistep process that explains the variety of Stat-mediated cellular
functions. This molecular machinery includes the primary stimuli,
activation of specific receptors and transactivation of co-receptors,
a cross-talk of intracellular signaling pathways and finally, Stat
nuclear translocation and DNA binding. Our study provides
evidence that Stat1 nuclear transport and DNA binding in a stage-
specific manner along the monocyte/macrophage pathway is
mediated by the shuttle protein nucleolin. Our results also suggest
that nucleo-cytoplasmic shuttle may play a significant role in the
modulation of gene expression that occur during monocyte
differentiation. The revealed requirement of nucleolin for Stat1
nuclear translocation was surprising, since the molecular mecha-
nisms of Stat1 nuclear transport have been extensively studied
before. Thus, Stat1 can associate with specific transport factors of
the importin family [46-48] or directly interact with the NPC [36].
Also an unusual nuclear import signal that specifically regulates
the nuclear entry of tyrosine-phosphorylated dimeric Stat1,
termed dimer-specific NLS (dsNLS), was identified [49]. Our
findings add to these schemes a novel mechanism for Stat1 nuclear
transport, which involves NLS sequence of nucleolin. NLS
containing proteins are transported into the nucleus by importins.
The classic mono- or bipartite NLS typically contains a cluster of
basic residues that is recognized and bound by the NLS receptor
importin-a, which is further associated through a separate domain
Figure 7. Nucleolin gene silencing prevents nuclear Stat1
translocation. (A) THP-1 cells were infected with nucleolin-si
lentiviruses (Nclsi) or empty viruses (con). Three days post infection,
cells were cultivated for further 72 hrs without or with 2 nM PMA or
stimulated with INF-c for 2 hrs. Nuclear extracts were prepared,
separated by SDS-PAGE, and Stat1 nuclear translocation was visualized
by Western blotting using monoclonal anti-Stat1 antibody (upper
panel). The purity of cell fractionation was proved by reprobing the
membrane with anti-histone antibody (nuclear marker, middle panel)
and anti-b-tubulin IgG (cytoplasmic marker, lower panel). (B) Inhibition
of the Stat1 nuclear translocation is shown by confocal microscopy
studies in Nclsi infected THP-1 cells stimulated as indicated. Cells were
fixed and permeabilized, and monoclonal anti-Stat1 antibody and
corresponding Alexa 488-coupled secondary IgG were used for staining
(green colour). Nuclear compartments were visualized by simultaneous
DNA labelling with DRAQ5 (red colour). The fluorescence cell images
were captured using a Leica TCS-SP2 AOBS confocal microscope (Leica
Microsystems). All images were taken with oil-immersed x63 objective,
NA=1.4. Resolution 102461024.
doi:10.1371/journal.pone.0008302.g007
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Figure 8. Stat1-nucleolin complex is specific for the differentiation step of monocytes to macrophages and regulates
expression of the macrophage scavenger receptor CD36. (A) Peripheral blood CD34+ cells were stimulated with M-CSF, to induce
differentiation to the monocyte/macrophage specific unilineage. Nucleolin downregulation in the CD34+ cells was achieved by lentiviral
gene silencing. Cells were fixed, permeabilized, and stained using polyclonal anti-nucleolin antibody (green colour), monoclonal anti-Stat1
antibody (red colour), and the corresponding Alexa-coupled secondary antibodies; simultaneous DNA labelling with DAPI (blue colour) was
performed to visualize the nuclear compartment. The merged confocal images of Ncl-Stat1-DAPI triple stained CD34+ cells taken by a Leica
TCS-SP2 AOBS confocal microscope are shown in the right panel. (B) Nucleolin-GST pull-down assay with whole cell extracts from monocytic
THP-1 cells and PLB-985, differentiated to a neutrophilic phenotype by DMSO treatment. Eluates were analyzed by Western blotting; GST
glutathione agarose was used as control. Crude cell lysates show equal Stat1 expression in PLB-985 cells. (C) THP-1 cells, lentiviral Nclsi-
pLVTHM (Nclsi) infected or with empty lentiviruses (con) treated, were analyzed by FACS after induction of monocyte/macrophage
differentiation by PMA. Cell surface expressions of CD11b and CD36 are shown.
doi:10.1371/journal.pone.0008302.g008
Stat1-Nucleolin Complex
PLoS ONE | www.plosone.org 8 December 2009 | Volume 4 | Issue 12 | e8302
with importin-b [50,51]. Although it cannot be excluded that the
nucleolin-Stat1 complex interacts with importins, our cross-linking
experiments do not support this implication. Nucleolin, especially
the aminoterminal third, is highly phosphorylated [52,53], and the
efficiency of nucleolin shuttling depends on its phosphorylation
state [54]. There is a direct link between the grade of nucleolin
phosphorylation and the function of NLS for the nuclear
membrane passage through the NPC [18,19]. Therefore,
phosphorylation/dephosphorylation reactions might be a regula-
tory element of nucleolin localization. Stat1 phosphorylation as a
result of its activation upon monocyte differentiation has been
demonstrated [27,30,55]. Though we confirmed these observa-
tions of others, no specific requirement for phosphorylated Stat1
for nucleolin binding was determined (data not shown). Our
experiments with INFc suggest that Stat1 phosphorylation of itself
is not sufficient for Stat1 nuclear transport via nucleolin. In
agreement with this observation, nuclear translocation of other
Stats independently of tyrosine phosphorylation was recently
documented [56]. These intriguing issues need further studies.
Nuclear transport mechanisms play a fundamental role in
regulating the activity of transcription factors [57]. We provide
evidence that nucleolin, beyond mediating Stat1 import into the
nucleus, is a part of the Stat1-DNA binding complex. Transcrip-
tion factors can act as multiprotein complexes, whose components
may be involved in different aspects of transcriptional regulation.
Adaptor proteins and co-activators may serve for bridging the
specific transcription factor to the basic transcription machinery or
to facilitate the contact with histone acetylases and deacetylases,
which are required for the chromatin remodeling [22,58].
Interestingly, the N-terminal portion of nucleolin can bind to
DNA and histone H1 [59] and the C-terminus shows a helicase
activity [60]. Both could be responsible for the capacity of
nucleolin to remodel the chromatin structure, an important
process for the activation or repression of gene expression [61].
Our results show that association and nuclear translocation of
Stat1 and nucleolin is specific for the stage of monocyte/
macrophage differentiation. This association was found in
different human and murine cell lines and primary cells of
monocytic origin including hematopoietic progenitor cells stimu-
lated for monocyte-to-macrophage differentiation. Though being
expressed, Stat1 and nucleolin did not associate when cells were
stimulated to differentiate to neutrophils and in cells of non-
myeloid lineages. Furthermore, in our experiments using nucleolin
transgenes we show that IFNc-induced Stat1 nuclear translocation
does not utilize nucleolin and in particular its NLS sequence. Our
data support the possibility that the nucleolin-mediated Stat1
nuclear transport might represent a specialized pathway for the
time-coordinated control of Stat1-regulated gene expression in
myelopoiesis. From a clinical perspective, it would be interesting to
identify factors, which specifically induce this pathway in vivo. Our
results indicate that this pathway is most likely regulated via the
CSF-1/M-CSFR system. Conversely, we need to know whether a
paracrine or an autocrine mechanism is involved.
With the exception for some IFN-stimulated genes, the
cellular genes dependent on cytokine-activated Stat proteins
are poorly defined. Recent studies point to a novel function of
Stat1 in the pathogenesis of numerous diseases beyond
tumorigenesis and host defenses, such as atherosclerosis and
other cardiovascular disorders [62,63]. It has been shown that
myocardial ischemia and reperfusion induced a rapid activa-
tion of Stat1 [63,64]. This functional outcome from Stat1
activation was related to promoting apoptotic cell death upon
ischemia/reperfusion injury. A critical role of Stat1 as a sensor
responding to cellular stress was further demonstrated in vitro
and in vivo in endoplasmic reticulum stress-induced macro-
phage apoptosis and atherosclerotic plaque progression [65].
Stat1 may have an additional role in the early lesions that is
independent of macrophage cell death but rather related to
regulation of CD36 scavenger receptor expression and foam
cell formation [42]. These observations may explain, at least in
part, why Stat1 deficiency in apolipoprotein E-/- mice blocks
foam cell formation and early lesion development. Our results
suggest that nucleolin-directed Stat1 nuclear transport during
the course of macrophage maturation might represent a
specific pathway to regulate CD36 expression. Thus, we
observed that nucleolin silencing resulted in abrogation of
CD36 expression. The regulation of CD36 by Stat1 may be
important in other pathophysiological events involving CD36-
dependent lipid uptake and inflammation, such as diabetes
mellitus and the metabolic syndrome. Therefore, Stat1
inhibition could represent a target to reduce inflammation
and to prevent progression of these diseases. Elucidation of the
underlying molecular mechanisms of Stat1 regulation could
lead to enhanced understanding of these physiological and
pathophysiological processes. Our study indicates Stat1-
nucleolin interference as one of these mechanisms.
Figure 9. NLS sequence of nucleolin is necessary for the
nuclear translocation of Stat1. (A) For infection of monocytic
murine M1 cells, a full-length (FL) and a NLS sequence deleted (DNLS)
nucleolin cDNA from murine origin were used to generate lentiviral
particles. (B) Three days post infection with FL(Ncl), DNLS(Ncl), or empty
lentiviruses (con), M1 cells were stimulated for differentiation with TCM
or left non-stimulated. Cells were fixed and permeabilized, and stained
for Stat1 (monoclonal anti-Stat1 antibody and corresponding Alexa488-
coupled secondary antibody, green colour). Simultaneous DNA
labelling with DRAQ5 (red colour) was performed to visualize the
nuclear compartment. The translocation of Stat1 into the nucleus was
analyzed with a Leica TCS-SP2 AOBS confocal microscope.
doi:10.1371/journal.pone.0008302.g009
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Materials and Methods
Materials
High-quality commercial grade chemicals were purchased from
Sigma (St. Louis, MO), Merck (Darmstadt, Germany), and Roth
(Karlsruhe, Germany). Chemiluminescent signal enhancer was
obtained from NENTM Life Science Products, Inc. (Boston, MA).
The far-red fluorescent DNA dye DRAQ5 was from Biostatus
Limited Ltd. (Shepshed, UK). Aqua-Poly/Mount mounting media
was purchased from Polysciences, Inc. (Warington, PA). Oligonucle-
otides were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Antibodies
Monoclonal antibodies for Stat1 protein were from BD
Transduction Laboratories (Lexington, KY). Monoclonal anti-
nucleolin antibodies were purchased from Medical and Biological
Laboratories, Co, Ltd. (Nagoya, Japan) and from Santa Cruz
Biotechnology (sc-8031). Polyclonal antibodies for Stat1 (sc-345),
M-CSFR, histone H1 and b-tubulin were from Santa Cruz
Biotechnology. Polyclonal anti-phospho-M-CSFR (Tyr723) anti-
body was obtained from Cell Signaling Technology, Inc. (Danvers,
MA). FITC- or PE-conjugated specific antibodies or isotype-
matched controls for FACS analysis were obtained from
Immunotech (Marseilles, France), BD Pharmingen (San Diego,
CA), and Serotec (Oxford, UK). Fluorescent Alexa 488- and Alexa
594-conjugated secondary antibodies were from Molecular
Probes, Inc. (Eugene, OR). Horseradish peroxidase-conjugated
secondary antibodies were purchased from Jackson ImmunoR-
esearch Laboratories (West Grove, PA) and Santa Cruz, Inc.
Cell Culture
Peripheral blood mononuclear cells (PBMC) were isolated from
healthy volunteers using Biocoll Separation Solution (Biochrom
KG Seromed, Berlin, Germany) according to the standard
protocol. After density gradient centrifugation, pure monocyte
fraction (purity approx. 92%) was obtained by using an indirect
magnetic labeling system (Monocyte Isolation Kit II, Miltenyi
Biotec Inc., Auburn, CA), as advised by the manufacturers.
Monocytes were cultured in RPMI 1640 medium (Biochrom)
supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
100 U/ml penicillin and 100 mg/ml streptomycin. For stimula-
tion, 50 ng/ml CSF-1 (M-CSF) (R&D Systems, Minneapolis, MN)
was used for indicated time points.
The human U937 promyelocytic cell line (American Type
Culture Collection (ATTC), Manassas, VA) and the human
myeloid leukaemia cell line THP-1 (German Resource Centre for
Biological Material (DSMZ), Braunschweig, Germany) were
cultured in supplemented RPMI 1640 medium. Induction of
monocyte-to-macrophage differentiation was performed by cell
stimulation with 2–20 nM PMA (Sigma) for different time points.
M1 mouse myeloid leukemia cells (DSMZ) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Biochrom)
supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
100 U/ml penicillin and 100 mg/ml streptomycin. Monocyte-
macrophage differentiation was induced by cell stimulation with
conditioned media from THP-1 cells (TCM) as described [66].
The human myeloid leukemia cell line PLB-985 (DSMZ) was
cultured in supplemented RPMI 1640 medium. Induction of
neutrophil differentiation was performed by cell stimulation with
1.25% DMSO for 5 days.
Source of peripheral blood CD34+ cells were leukapheresis
products from healthy donors after stem cell mobilization with
recombinant granulocyte-colony stimulating factor (G-CSF). For
isolation of CD34+ cells, the CliniMACS system (Miltenyi Biotec,
Bergisch Gladbach, Germany) was used. The purity of the isolated
cells for CD34+ was .99%. The majority of the CD34+ cell
population (,80%) was double positive for the common leukocyte
antigen CD45 and the stem cell marker CD133. Cells were
cultivated in StemSpanRSFEM (Serum-free medium for expan-
sion and culture of hematopoietic cells) from StemCell Technol-
ogies Inc, supplemented with 100 ng/ml Stem Cell Factor (Cell
Systems), 50 ng/ml Flt3 ligand (Cell Systems), 20 ng/ml TPO
(thrombopoietin, Peprotech EC Ltd). Differentiation to the
monocytic lineage was initiated by 10 ng/ml human CSF-1
(M-CSF) (R&D Systems).
Plasmid Construction
The nucleolin constructs (DC(Ncl) aa284-aa707, and C(Ncl)
aa538-aa707) were generated from a human nucleolin cDNA
clone [53] and subcloned into the pSG5 vector (Stratagene, La
Jolla, CA). To generate the GST fusion proteins, the correspond-
ing constructs were cloned into the bacterial expression vector
pGEX-2T (Amersham Pharmacia Biotec Inc.) and expressed after
Isopropyl-1-thio-b-D-galactopyranoside (IPTG) induction in
DH5a E.coli strain.
Mouse nucleolin cDNA was obtained from the American Type
Culture Collection (ATCC; Manassas, VA). The sequence
encoding full-length mouse nucleolin was subcloned into pMT/
BiP/V5-His expression vector (Invitrogen, Carlsbad, CA). The
coding sequence for a FLAG epitope was introduced at the N-
terminus of nucleolin (pMT/BiP-N-FLAG-m-ncl) using Quick-
ChangeH site-directed mutagenesis kit (Stratagen, La Jolla, CA).
pMT/BiP-N-FLAG-m-ncl plasmid served as a template for
further cloning procedures. Constructs encoding N-terminus
FLAG-tagged wild-type mouse nucleolin and a mutant, in which
the NLS (encoded by nt 841 to 897) was deleted (DNLS) were
constructed and cloned in pcDNA3.1(+) vector (Invitrogen) using
standard PCR-mediated cloning procedures. For overexpression
of mouse nucleolin, lentivirus transfer vector pWPTS-adapter was
generated from the pWPTS-GFP vector by BamHI and SalI
cloning duplex. Full length mouse nucleolin cDNA and NLS
nucleolin mutant were transferred from pcDNA3.1(+) into
pWPTS-adapter in SalI and SpeI sites. Final construct
were designated as pWPTS-FL(Ncl) and pWPTS-DNLS(Ncl)
accordingly.
For nucleolin silencing, the target sites in human nucleolin
mRNA (Acc. #NM005381) for RNAi were determined using the
siRNA Selection Server (http://jura.wi.mit.edu/bioc/siRNAext/
home.php)41 and designed as oligonucleotides encoding short
hairpin RNAs (shRNAs). The following complimentary sequences
were selected:
Nuc 64
G AGG TAG AAG AAG ATA GTT
Nuc 719
A CGC TAA AGA AGC TTT AAT
For cloning in pLVTHM vector, the following duplexes were
used:
Nuc 64
CGCGTCCCCGAGGTAGAAGAAGATAGTTTTCAAGA-
GAAACTATCTTCTTCTACCTCTTTTTGGAAAT
CGATTTCCAAAAAGAGGTAGAAGAAGATAGTTTCTC-
TTGAAAACTATCTTCTTCTACCTCGGGGA
Nuc 719
CGCGTCCCCACGCTAAAGAAGCTTTAATTTCAAGA-
GAATTAAAGCTTCTTTAGCGTTTTTTGGAAAT
CGATTTCCAAAAAACGCTAAAGAAGCTTTAATTCTC-
TTGAAATTAAAGCTTCTTTAGCGTGGGGA
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For downregulation of nucleolin expression by a lentivirus
containing nucleolin-specific siRNA, pLVTH-Nclsi plasmid was
generated by ligation of the oligonucleotide duplex Nclsi in MluI
and ClaI sites of pLVTHM (Tronolab, Switzerland). Nuc 64
showed more extended silencing property and was therefore
selected for the next experiments.
For M-CSFR overexpression, the lentivirus pDEST-lenti
transfer vector was generated by blant ligation Gateway Cassete
rfa-verB (Invitrogen) in PmeI and SmaI sates of the pLV-
tRKRAB-Red vector (Tronolab). Entry clones for the transfer of
the M-CSFR were produced by cloning the PCR products in the
pENTR/D TOPO plasmid (Invitrogen). For M-CSFR overex-
pression, pEXPR clones were generated by site-specific recombi-
nation between pDEST-lenti and pENTR/D TOPO-M-CSFR by
Gateway LR Clonase Enzyme mix (Invitrogen).
Lentiviral Vector Production and Cell Infection
For experiments with M-CSFR constructs, pCMV-dR8.74,
pMD.2G (Tronolab) and pEXPR plasmids were co-transfected
(using ratio pLVTHM:pCMV-dR8.74:pMD2G=3:2:1) into 293T
cells by PerFectin transfection reagent (Genlantis, San Diego, CA)
as recommended by manufacturer. After 48 h post transfection,
the viral particles containing cell supernatants were harvested,
filtered, concentrated, and stored at 270uC for future use.
pLVTH-Nclsi, pWPTS-FL(Ncl), pWPTS-DNLS(Ncl) vectors were
used instead pEXPR for nucleolin silencing or overexpression as
stated above.
For infection, 0.5–0.76106 cells/0.6 ml in the presence of 16 mg
polybrene and 0.4 ml virus stock were centrifuged (1,0006g,
30 min, RT) and incubated at 37uC with 5% CO2 for 4 to 5 hrs.
Cells were transferred into 2 ml for overnight and then into 6 ml
fresh RPMI medium for further cultivation.
Quantitative RT-PCR Analysis of Nucleolin
The total RNA samples was isolated from THP-1 cells using
QIAGEN QiaSpin miniprep kit and DNAse kit (QIAGEN, Hilden,
Germany), and real-time quantitative RT-PCR for nucleolin mRNA
was performed on a TaqMan ABI 7700 Sequence Detection System
(Applied Biosystems, Foster City, CA, USA). GAPDH was used as
a reference gene. The following oligonucleotide primers and probes
were used: GAPDH, 59-GAAGGTGAAGGTCGGAGTC-39
(sense), 59-GAAGATGGTGATGGGATTC-39 (antisense), 6-
FAM-CAAGCTTCCCGTTCTCAGCC-TAMRA (probe); Nu-
cleolin, 59- TCGCGAAGGCAGGTAAAAA-39 (sense), 59- CGAC-
CTCTTCTCCACTGCTATCA-39 (antisense), 59- 6-FAM-AAG-
GTGACCCCAAGAAAATGGCTCCTC-TAMRA (probe).
Cell Lysis and Immunoblotting
Non-stimulated cells were washed twice with PBS [phosphate
buffered saline], stimulated, adherent cells were detached by
adding 5 mM EDTA [ethylene diamine tetramine acetate] in
PBS. Cells were washed twice with ice cold PBS, resuspended in
lysis buffer (20 mM Tris-HCl, pH 8.0, 138 mM NaCl, 10%
glycerol, 2 mM EDTA, 1% Triton X-100, and protease inhibitors
1 mM PMSF [phenylmethylsulfonyl fluoride], 10 mg/ml aproti-
nin, 10 mg/ml leupetin, 0.3 mM sodium orthovanadate), and put
on ice for 10 min. Lysates were clarified by centrifugation at
13,000 rpm for 10 min. Western blotting was performed as
described elsewhere [67].
Fusion Protein Precipitation Assay (Pull Down Assay)
Nucleolin and/or Stat1 GST fusion proteins immobilized on
glutathione- agarose beads (Sigma) were used for affinity
precipitation. Cell lysates containing 800 to 1,500 mg protein
were incubated for 1 hr at RT or overnight at 4uC with
immobilized GST fusion protein. GST- matrix was used as
control affinity matrix. Precipitates were washed three times with
Tris-buffed saline containing 0.1% Tween20 (TBS-T). Precipitat-
ed proteins were eluted with Laemmli sample buffer containing
20 mM dithiotreitol (DTT), and were used for SDS-PAGE and
Immunoblotting with corresponding antibodies.
Immunoprecipitation and Cross-Linking
Immunoprecipitation studies were performed as described
[67,68]. For cross-linking, 2 mM of the bifunctional chemical
cross-linker bis(sulfosuccinimidyl) suberate (BS3, Pierce, Rockford,
IL) was added to cytosolic fractions for 30 min at RT. The
reaction was stopped by adding Tris to a final concentration of
50 mM and incubated for further 15 min. Cross-linked samples
were used for immunprecipitation and Western blotting.
Nuclear Extract Preparation
The cell pellet of approx. 3.56107 cells was washed,
resuspended in 1 ml hypotonic buffer (10 mM HEPES pH 7.9,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT) and incubated on
ice for 30 min. After sonication and centrifugation (6006g, 5 min,
4uC), the pellet was resuspended in 600 ml 0.25 M sucrose in
buffer A (50 mM Tris-HCl, pH 7.4, 5 mM MgSO4, 2 mM DTT),
laid over 400 ml 0.25 M sucrose in buffer A and centrifuged
(7006g, 7 min, 4uC). The pellet was resuspended in 6 ml 1.4 M
sucrose in buffer A and laid between 4 ml 2.2 M sucrose and 2 ml
0.25 M sucrose in buffer A. After ultracentrifugation (100,0006g
for 45 min at 4uC, Beckmann Sw40Ti), the pure nuclei were
resuspended in 40 ml of a low salt buffer (20 mM HEPES, pH 7.9,
25% glycerol, 20 mM KCl, 0.2 mM EDTA, 0.5 mM DTT). 30 ml
high salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 1.5 mM
MgCl2, 800 mM KCl, 0.2 mM EDTA, 0.5 mM DTT), were
added and incubated on ice for 20 min, followed by centrifugation
at 13,0006g (5 min, 4uC). The supernatant was dialyzed against
20 mM HEPES, pH 7.9, 20% glycerol, 100 mM KCl, 0.2 mM
EDTA, 0.5 mM DTT).
For crude nuclear extracts, the cell pellet of 1.56107 monocytes
was resuspended in 400 ml ice cold extract buffer (20 mM HEPES,
pH 7.9, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT) containing
10 mM KCl, placed on ice for 20 min and lysed in 0.5% Nonidet
P-40. After centrifugation, the pellet was resuspended in 50 ml ice
cold extract buffer containing 20% glycerol and 400 mM NaCl
and incubated at 4uC for 30 min. After centrifugation, crude
nuclear extracts were microdialyzed against PBS, used immedi-
ately or stored at 280uC.
Electric Mobility Shift Assay (EMSA)
Electrophoretic mobility shift assays were performed as
described previously [69]. Binding reaction was performed for
30 min at 25uC with 2–4 mg of whole cell extract. For antibody-
supershift and competition analysis protein extracts were pre-
incubated with 3 mg of Stat1 polyclonal or nucleolin monoclonal
antibodies for 30 min on ice. For oligonucleotide competition 5-
fold excess of unlabeled oligonucleotides were added to the
reaction. The following double-stranded oligonucleotides were
used:
GAS sense, 59-CATGTTATGCATATTCCTGTAAGTG-39
GAS anti-sense, 59-CATGCACTTACAGGAATATGCATA-
A-39
H2K sense 59-GATCCAGGGCTGGGGATTCCCCATCTC-
CACAGG-39
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H2K anti-sense 59-GTCCCGACCCCTAAGGGGTAGAGG-
TGTCCCTAG-39
Immunofluorescence Confocal Microscopy
Suspension cells, primary human blood monocytes or mono-
cytic cells (THP-1, U937, M1, CD34+), were pelleted on
microscope slides by using a cytospinner (Hettich, Tuttlingen
Germany, 2006g, 7 min). Stimulated, adherent cells were seeded
and cultured on glass coverslips. Cells were fixed, stained and
mounted as described by us previously [67]. Fc receptors were
blocked with Fc receptor blocking reagents (Miltenyi Biotech or
BD Biosciences). DNA staining was performed with far-red
fluorophore DRAQ5 (Biostatus Limited Ltd., 1:100, 15 min at
RT) or with DAPI [49,6-Diamidin-29-phenylindoldihydrochlorid]
(Invitrogen, 300 nM in PBS, 5 min at RT).
FACS Analysis
Phenotypic expression of CD11b, CD36, and CD206 was
quantified by FACS (FACscan; Becton Dickinson, Heidelberg,
Germany). Briefly, adherent cells were detached with 5 mM
EDTA in PBS. Cells were collected by centrifugation, incubated
with Fc receptor blocking reagents and stained with the
corresponding FITC- or PE-conjugated specific antibody or the
isotype matched control. For quantitative analysis of nucleolin,
cells were fixed with 2% paraformadehyde in PBS for 15 min at
RT and permeabilized with an ice-cold mixture of methanol and
acetone (1:1) at 220uC for 20 min. After incubation with
monoclonal anti- nucleolin IgG for 30 min at RT, the
Alexa488-conjugated secondary antibody was added for further
15 min at RT. Measurement of mean fluorescence intensity (MFI)
and analysis of data were done using Cell Quest Software. 10,000
events per sample were collected.
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